Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,651–4,675 of 7,816 matching trials · page 187 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Photobiomodulation to Improve Cognition in TBI, With fMRI NCT04230577 Real LED Intervention; Sham LED Intervention Runs in: United States · 1 site |
EARLY_PHASE1 other |
UNKNOWN | 20 | Boston VA Research Institute, Inc. OTHER |
2022-02-25 |
|
Cognitive-driven ADL Impairment as a Predictor for PDD NCT03687203 Functional Activities Questionnaire Runs in: Germany · 1 site |
NA other |
COMPLETED | 182 | University Hospital Tuebingen OTHER |
2022-02-24 |
|
Effects of the Combining Physical Exercise and Cognitive Training for the Community-based Elderly NCT05225181 perform physical exercise; cognitive training; control group Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 90 | Chang Gung Memorial Hospital OTHER |
2022-02-24 |
|
Norwegian COgnitive Impairment After STroke (NorCOAST) Study NCT02650531 Runs in: Norway · 1 site |
NA other |
COMPLETED | 816 | Norwegian University of Science and Technology OTHER |
2022-02-23 |
|
Transcranial Alternating Current Stimulation Combined With 40Hz Sound Stimulation for Treatment Alzheimer's Disease NCT05251649 tACS combined with 40 Hz sound stimulation; Transcranial alternatin... Runs in: China · 1 site |
NA other |
UNKNOWN | 60 | Chinese PLA General Hospital OTHER |
2022-02-23 |
|
Energy Balance in Huntington's Disease. A Multidisciplinary Study Approach for a Complex Problem (BEHD-EM) NCT05250323 observational tests in face-to-face visit Runs in: Spain · 1 site |
NA other |
COMPLETED | 30 | Hospital Universitario de Burgos OTHER |
2022-02-22 |
|
Grounding Effect on Alzheimer's Disease NCT05246332 Grounding Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 22 | Chang Gung Memorial Hospital OTHER |
2022-02-18 |
|
The Effect of Simulation in Gaining Skills to Nursing Students NCT05246501 Simulation; No simulation Runs in: Turkey (Türkiye) · 1 site |
NA other |
UNKNOWN | 71 | Saglik Bilimleri Universitesi OTHER |
2022-02-18 |
|
Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders NCT03832413 DELPhI (TMS-EEG analysis) Runs in: Israel · 1 site |
NA other |
COMPLETED | 193 | QuantalX Neuroscience INDUSTRY |
2022-02-16 |
|
Development of Automated Analysis to Electroencephelogram (EEG) Data in Patients Treated at the Sagol Hyperbaric Medicine and Research Center at the Years 2017-2019. NCT04095377 No intervention, this is a retrospective study. Runs in: Israel · 1 site |
NA other |
COMPLETED | 875 | QuantalX Neuroscience INDUSTRY |
2022-02-16 |
|
The Effects of a Hybrid Face-To-Face and Online Mode of Delivering a Mindfulness-Based Dementia Caregiving Programme for Family Caregivers of Persons With Dementia: A Randomized Controlled Trial NCT05242614 The Hybrid Mindfulness-based Dementia caregiving program (MBDCP); P... |
NA other |
UNKNOWN | 290 | The Hong Kong Polytechnic University OTHER |
2022-02-16 |
|
Risk Reduction for Alzheimer's Disease NCT02913664 Angiotensin II receptor blocker (ARB, losartan) and calcium channel... Runs in: United States · 4 sites |
PHASE2|PHASE3 other |
COMPLETED | 513 | University of Texas Southwestern Medical Center OTHER |
2022-02-15 |
|
SCI-110 for Alzheimer Disease and Agitation NCT05239390 SCI -110 Runs in: Israel · 1 site |
PHASE2 other |
UNKNOWN | 20 | The Israeli Medical Center for Alzheimer's OTHER |
2022-02-14 |
|
Comprehensive Support for Alzheimer's Disease Caregivers NCT00362284 NYUCI-AC Runs in: United States · 2 sites |
NA other |
COMPLETED | 161 | University of Minnesota OTHER |
2022-02-11 |
|
Anger Control Training for Youth With Tourette Syndrome NCT00486551 Anger control training Runs in: United States · 1 site |
NA other |
COMPLETED | 26 | Yale University OTHER |
2022-02-11 |
|
Effects of Aerobic Exercise for Treating Alzheimer's Disease NCT01954550 Cycling exercise; Range of motion/stretching exercise Runs in: United States · 1 site |
NA other |
COMPLETED | 96 | University of Minnesota OTHER |
2022-02-11 |
|
Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease NCT03225833 WVE-120101; Placebo Runs in: Australia; Canada; Denmark; France; Germany; Poland; Unit... · 21 sites |
PHASE1|PHASE2 other |
TERMINATED | 61 | Wave Life Sciences USA, Inc. INDUSTRY |
2022-02-10 |
|
Imagery in Early Stages of Dementia NCT05232526 Mental imagery (MI) and exercise program; Mental Imagery and Exerci... Runs in: Greece · 1 site |
NA other |
UNKNOWN | 105 | University of West Attica OTHER |
2022-02-10 |
|
Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease NCT01306929 pridopidine |
PHASE2 other |
COMPLETED | 134 | Prilenia INDUSTRY |
2022-02-09 |
|
Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease NCT04617847 WVE-120101 Runs in: Australia; Canada; Denmark; France; Germany; Poland; Unit... · 18 sites |
PHASE1|PHASE2 other |
TERMINATED | 27 | Wave Life Sciences USA, Inc. INDUSTRY |
2022-02-09 |
|
Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease NCT04617860 WVE-120102 Runs in: Australia; Canada; Denmark; France; Germany; Poland; Unit... · 20 sites |
PHASE1|PHASE2 other |
TERMINATED | 36 | Wave Life Sciences USA, Inc. INDUSTRY |
2022-02-09 |
|
Cognitive/Physical Computer-Game Blended Training With Personalized Brain Network Activation Technology for the Elderly NCT02417558 Alterniity Augmented Reality (AAR); VideoGrade |
NA other |
COMPLETED | 607 | XtremeVRI AG INDUSTRY |
2022-02-08 |
|
Investigating HD-tDCS in Improving Word Finding and Memory Retrieval in Individuals With MCI NCT03446508 Active frontal; Active parietal; Sham Runs in: United States · 1 site |
NA other |
WITHDRAWN | 0 | The University of Texas at Dallas OTHER |
2022-02-08 |
|
Smart Cupboard-based System for Memory Assessment in Alzheimer's Patients NCT05202197 Smart cupboard Runs in: Spain · 1 site |
NA other |
COMPLETED | 13 | Universidad de Zaragoza OTHER |
2022-02-07 |
|
Dual-Task Zumba Gold for Improving the Cognition of Older Adults With MCI NCT04788238 Dual-Task Zumba Gold Runs in: Philippines · 1 site |
NA other |
UNKNOWN | 60 | The Hong Kong Polytechnic University OTHER |
2022-02-04 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial